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DESCRIPTION
A 12-year-old African American woman presented to a plastic surgeon
with a 1-year history of a slowly growing soft tissue mass behind her
leftear. Accordingto her, shehad chickenpox and a residualpock mark
behind that ear. As a result of irritation in that area from her glasses, she
developedacosmeticallydeformingkeloidshownontheleft.Thekeloid
was subsequently excised, but 1 year later, she developed recurrence of
the keloid that measured 11 × 4 cm. The recurrent keloid is pictured on
the right.
NEXTQUESTIONS
1. What is the pathogenesis of a keloid?
2. What are the different treatment modalities for keloids?
3. How can the recurrence of keloids be prevented?
NEXT BACKDISCUSSION
Keloids can be a difﬁcult condition to manage primarily because of the high
rate of recurrence associated with them. The patient described in this case de-
veloped multiple recurrences of her left postauricular keloid despite multiple
excisions and radiation therapy. The picture appearing later was taken during
the patient’s last visit demonstrating the residual effects of multiple excisions
and radiation therapy. She was 34 years old at the time, which is 22 years after
the initial presentation. During this period of 22 years, the patient underwent
7 surgical excisions, 3 radiation treatments, and 3 corticosteroid injections.
Both keloids and hypertrophic scars are ﬁbroproliferative disorders of the
skin that results from aberrant wound healing. Clinically, they can be differ-
entiated by the extent of scar involvement. Dense ﬁbrous tissue that grows
beyond the boundaries of the original wound and rarely regresses is a keloid.
In contrast, hypertrophic scars lie within the boundaries of the wound and
undergo regression after a static phase.1 Keloids are more commonly seen
in individuals between the age of 10 and 30 and those of African, Asian,
or Hispanic descent. The incidence of keloids can be as high as 16% in the
African and Hispanic populations, which suggests the presence of a genetic
component.2 Other risk factors that promote the development of keloids in-
cludemechanicalforce,woundinfection,andforeignbodyreactions.3 Careful
avoidance of these risk factors is important to prevent development of keloids
after surgery or injury.
Despite extensive inquiries, the pathogenesis of keloids remains poorly
understood. The current theories on keloid development often center on dys-
functional ﬁbroblasts that lead to overproduction of type I procollagen and
exhibit lower rates of apoptosis. In addition, the elevated levels of transform-
ing growth factor β, platelet derived growth factor, and vascular endothelial
growth factor found within keloids promote ﬁbroblast proliferation and col-
lagen production.1 In addition, a study by Granick et al3 showed that early
telomerase activity may be responsible for the proliferation of keloids in their
early stages.
A wide array of treatment modalities exists for management of keloids;
however, no single optimal algorithm exists. Surgical excision is often used
but should be combined with adjuvant therapy due to high rates of recurrence
when used alone, up to 45% to 100%.4 Intralesional corticosteroids, primarily
triamcinolone and radiotherapy can both be used as either monotherapy or
adjuvant to surgical excision. The effectiveness of corticosteroid injection
monotherapyhasbeenreportedtobe50%to82%.4 Theresultsofoneprospec-
tive study suggest that triamcinolone alone and the combined treatment of
surgical excision with adjuvant corticosteroids were similarly effective.5
The combination of surgery and radiotherapy achieves a success rate of
NEXT BACK67% to 98%, but the risk of inducing malignancy for treating a benign lesion
withradiotherapyisanimportantconcern.4 Someauthorshavearguedthatthe
riskofcarcinogenesisisverylowwhenthecorrectdosageisusedandadequate
precautions are taken.6 Radiotherapy is favored in areas without underlying
viscerasuchastheextremities.Itshouldnotbeusedinthepediatricpopulation
or pregnant women because of the theoretical risk of inducing malignancy.7
Other therapies for treating and preventing recurrence of keloids include
topical 5-ﬂuorouracil, imiquimod, silicone gel products, compression therapy,
laser, and cryotherapy.
The decision of which therapy to be utilized often must be made on an
individualized basis. In patients with a few or small keloid lesions, radical
treatment with surgical excision plus adjuvant therapy such as radiation or
corticosteroid may be used as the ﬁrst-line treatment. The alternative method
is a nonsurgical monotherapy such as corticosteroid, cryotherapy, laser, or
antitumor agents. In patients with multiple or large keloids, a comprehensive
discussion regarding the goals of treatment and expectations of the patient
must be performed before initiating therapy. Treatment strategies include
mass reduction surgery or symptomatic multimodal therapy consisting of a
combinationof thenonsurgicaltreatmentsincludingcorticosteroidinjections,
cryotherapy, laser, antitumor agents, compression, and gel sheets. Recurrence
of disease often requires switching to an alternative treatment modality.4
While the arsenal of therapies for the management keloids is quite large,
itremainsacomplicatedconditiontotreatwithahighincidenceofrecurrence.
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